What is NDC 55150-471?

55150-471 is the product NDC for Vancomycin hydrochloride, Vancomycin hydrochloride 1.25 g/25mL injection, powder, lyophilized, for solution, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Vancomycin hydrochloride?

140 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Vancomycin hydrochloride NDC 55150-471

NDC codes

FDA NDC Directory

Product NDC (as listed)55150-471Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55150-0471Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55150-471-10	5515004711055150047110	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-471-10) / 25 mL in 1 VIAL, SINGLE-DOSEMarketed from Aug 4, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vancomycin hydrochloride
Generic name (nonproprietary): vancomycin hydrochloride
Active ingredients: Vancomycin hydrochloride — 1.25 g/25mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Eugia US LLCNDC labeler code 55150
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217401
Marketing start: Aug 4, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Glycopeptides (Chemical structure)
Identifiers: Product ID 55150-471_9aa42538-c84e-4886-8d3d-a7dfded5120fSPL ID 9aa42538-c84e-4886-8d3d-a7dfded5120fSPL set ID 9aa42538-c84e-4886-8d3d-a7dfded5120fRxCUI 2049888, 2049890UNII 71WO621TJDUPC 0355150471010, 0355150472017
Pharmacologic class: Glycopeptide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455150047110 followed by a unit qualifier and the quantity

Package 55150-0471-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 5, 2023.

Indications (excerpt from the label)

Vancomycin hydrochloride for injection is a glycopeptide antibacterial indicated in adult and pediatric patients (neonates and older) for the treatment of: Septicemia ( 1.1 ) Infective Endocarditis ( 1.2 ) Skin and Skin Structure Infections ( 1.3 ) Bone Infections ( 1.4 ) Lower Respiratory Tract Infections ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin hydrochloride for injection and other antibacterial drugs, vancomycin hydrochloride for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. ( 1.6 ) 1.1 Septicemia Vancomycin hydrochloride for injection…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55150-471

What is NDC 55150-471?: 55150-471 is the product NDC for Vancomycin hydrochloride, Vancomycin hydrochloride 1.25 g/25mL injection, powder, lyophilized, for solution, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Vancomycin hydrochloride.
What is the active ingredient?: Vancomycin hydrochloride.
Who is the labeler?: Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vancomycin hydrochloride?: 140 other product NDCs are listed under this name. See all Vancomycin hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Vancomycin hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Vancomycin Hydrochloride	Vancomycin hydrochloride 10 g/100mL	Injection, Powder, Lyophilized, For solutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-958	68462-0958-10
Vancomycin Hydrochloride	Vancomycin hydrochloride 5 g/100mL	Injection, Powder, Lyophilized, For solutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-957	68462-0957-05
Vancomycin Hydrochloride	Vancomycin hydrochloride 1.25 g/1	Injection, Powder, For solutionIntravenous, Oral	Avenacy, LLC	83634-115	83634-0115-30
Vancomycin Hydrochloride	Vancomycin hydrochloride 750 mg/1	Injection, Powder, For solutionIntravenous, Oral	Avenacy, LLC	83634-114	83634-0114-20
Vancomycin Hydrochloride	Vancomycin hydrochloride 1.5 g/1	Injection, Powder, For solutionIntravenous, Oral	Avenacy, LLC	83634-116	83634-0116-30
vancomycin hydrochloride	Vancomycin hydrochloride 125 mg/1	CapsuleOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-967	23155-0967-2523155-0967-78
vancomycin hydrochloride	Vancomycin hydrochloride 250 mg/1	CapsuleOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-968	23155-0968-2523155-0968-78
vancomycin hydrochloride	—	Kit	Aurobindo Pharma Limited	59651-669	59651-0669-0359651-0669-55
vancomycin hydrochloride	—	Kit	Aurobindo Pharma Limited	59651-670	59651-0670-0359651-0670-55
Vancomycin Hydrochloride	Vancomycin hydrochloride 250 mg/1	CapsuleOral	PAI Holdings, LLC dba PAI Pharma	0121-1033	00121-1033-2000121-1033-50

All 141 Vancomycin hydrochloride NDCs

Other NDCs under ANDA 217401

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217401
Product	Strength	Form · route	Labeler	Product NDC
Vancomycin hydrochloride	Vancomycin hydrochloride 1.5 g/30mL	Injection, Powder, Lyophilized, For solutionIntravenous	Eugia US LLC	55150-472